# US 2022/0023506 A1 · JAB1 Inhibitory Compositions for Ossification and Methods Related Thereto

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0023506 A1
- Document ID: US20220023506A1
- Status: Published application
- Kind: A1
- Application number: 17/501,463
- Filed: 2021-10-14
- Published: 2022-01-27
- Earliest claimed: 2011-02-24
- Assignees: Emory University; The United States Government as represented by the Department of Veterans Affairs
- Applicants: Emory University; The United States Government as Represented by the Department of Veterans Affairs
- Inventors: Scott D. Boden; Sreedhara Sangadala
- Web page: https://patentgrep.com/patent/US20220023506A1

## CPC

- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/46: with phosphorus-containing inorganic fillers
- A61L 2300/414: Growth factors
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- A61L 2430/06: for cartilage reconstruction, e.g. meniscus
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

This disclosure relates to compounds and compositions for forming bone and methods related thereto. In certain embodiments, the disclosure relates to methods of forming bone comprising implanting a bone graft composition comprising a growth factor such as BMP in a subject at a site of desired bone growth or enhancement in combination with a JAB1 blocker.

## Claims

### Claim 1

A method of forming bone comprising implanting a bone graft composition comprising a 4-(phenoxy)-quinoline derivative optionally comprising a growth factor in a subject at a site of desired bone growth,
wherein the 4-(phenoxy)-quinoline derivative has formula IA,
or salts thereof, wherein
X is NH or O;
R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 and R11 are each the same or different hydrogen, alkyl, halogen, nitro, cyano, hydroxy, amino, mercapto, formyl, carboxy, alkanoyl, carbamoyl, alkoxy, alkylthio, alkylamino, or (alkyl)2amino.

### Claim 2 (depends on 1)

The method of claim 1, further comprising a growth factor.

### Claim 3 (depends on 2)

The method of claim 2, wherein the growth factor is a bone morphogenetic protein.

### Claim 4 (depends on 3)

The method of claim 3, wherein the bone morphogenetic protein is BMP-2, BMP-7, BMP-6, or BMP-9.

### Claim 5 (depends on 1)

The method of claim 1, wherein the bone graft composition comprises collagen.

### Claim 6 (depends on 1)

The method of claim 1, wherein the bone graft composition comprises calcium phosphates.

### Claim 7 (depends on 1)

The method of claim 1, wherein the bone graft composition comprises a hydrogel matrix

### Claim 8 (depends on 1)

The method of claim 1, wherein the 4-(phenoxy)-quinoline derivative is 4-(4-bromo-3-methylphenoxy)-6,7-dimethoxyquinoline or salts thereof.

### Claim 9 (depends on 1)

The method of claim 1, wherein R1, R2, R3, R4, R7, R8, and R11 are hydrogen.

### Claim 10

A method of forming bone comprising
a) implanting a bone graft composition comprising a growth factor in a subject at a site of desired bone growth and
b) administering a pharmaceutical composition comprising a 4-(phenoxy)-quinoline derivative to the subject,
wherein the 4-(phenoxy)-quinoline derivative has formula IA,
or salts thereof, wherein
X is NH or O;
R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 and R11 are each the same or different hydrogen, alkyl, halogen, nitro, cyano, hydroxy, amino, mercapto, formyl, carboxy, alkanoyl, carbamoyl, alkoxy, alkylthio, alkylamino, or (alkyl)2amino.

### Claim 11 (depends on 10)

The method of claim 10, wherein the 4-(phenoxy)-quinoline derivative is 4-(4-bromo-3-methylphenoxy)-6,7-dimethoxyquinoline or salts thereof.

### Claim 12 (depends on 10)

The method of claim 10, wherein the bone graft further comprises a 4-(phenoxy)-quinoline derivative.

### Claim 13 (depends on 10)

The method of claim 10, wherein the growth factor is a bone morphogenetic protein.

### Claim 14 (depends on 13)

The method of claim 13, wherein the bone morphogenetic protein is BMP-2, BMP-7, BMP-6, or BMP-9.

### Claim 15 (depends on 10)

The method of claim 10, wherein the bone graft composition comprises collagen.

### Claim 16 (depends on 10)

The method of claim 10, wherein the bone graft composition comprises calcium phosphates.

### Claim 17 (depends on 10)

The method of claim 10, wherein the bone graft composition comprises a hydrogel matrix.

### Claim 18 (depends on 10)

The method of claim 10, wherein R1, R2, R3, R4, R7, R8 and R11 are hydrogen.
